Why the study?
Heart failure prevalence and mortality are rising in China with aging, and current treatment effects and prognosis remain unsatisfactory, making new therapeutic targets necessary.
This review highlights the importance of exploring pathogenic mechanisms and identifying new therapeutic targets for heart failure, particularly in the context of China's aging population.
Supports HF research prioritization in China's aging population; leaves open identification of specific mechanisms and targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yanli Liu (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: